98 related articles for article (PubMed ID: 23648796)
1. Protoapigenone derivatives: albumin binding properties and effects on HepG2 cells.
Poór M; Li Y; Kunsági-Máté S; Varga Z; Hunyadi A; Dankó B; Chang FR; Wu YC; Kőszegi T
J Photochem Photobiol B; 2013 Jul; 124():20-6. PubMed ID: 23648796
[TBL] [Abstract][Full Text] [Related]
2. Direct semi-synthesis of the anticancer lead-drug protoapigenone from apigenin, and synthesis of further new cytotoxic protoflavone derivatives.
Hunyadi A; Chuang DW; Danko B; Chiang MY; Lee CL; Wang HC; Wu CC; Chang FR; Wu YC
PLoS One; 2011; 6(8):e23922. PubMed ID: 21912610
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
4. First total synthesis of protoapigenone and its analogues as potent cytotoxic agents.
Lin AS; Nakagawa-Goto K; Chang FR; Yu D; Morris-Natschke SL; Wu CC; Chen SL; Wu YC; Lee KH
J Med Chem; 2007 Aug; 50(16):3921-7. PubMed ID: 17622129
[TBL] [Abstract][Full Text] [Related]
5. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity.
Huang XH; Xiong PC; Xiong CM; Cai YL; Wei AH; Wang JP; Liang XF; Ruan JL
Phytomedicine; 2010 Oct; 17(12):930-4. PubMed ID: 20381325
[TBL] [Abstract][Full Text] [Related]
7. Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Csekes E; Vágvölgyi M; Hunyadi A; Račková L
Life Sci; 2020 Nov; 260():118419. PubMed ID: 32931795
[TBL] [Abstract][Full Text] [Related]
8. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1.
Yuan Q; Liu Z; Xiong C; Wu L; Wang J; Ruan J
Bioorg Med Chem Lett; 2011 Jun; 21(11):3427-30. PubMed ID: 21515048
[TBL] [Abstract][Full Text] [Related]
9. Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'-
Vágvölgyi M; Girst G; Kúsz N; Ötvös SB; Fülöp F; Hohmann J; Servais JY; Seguin-Devaux C; Chang FR; Chen MS; Chang LK; Hunyadi A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842358
[TBL] [Abstract][Full Text] [Related]
10. Fern plant-derived protoapigenone leads to DNA damage, apoptosis, and G(2)/m arrest in lung cancer cell line H1299.
Chiu CC; Chang HW; Chuang DW; Chang FR; Chang YC; Cheng YS; Tsai MT; Chen WY; Lee SS; Wang CK; Chen JY; Wang HM; Chen CC; Liu YC; Wu YC
DNA Cell Biol; 2009 Oct; 28(10):501-6. PubMed ID: 19630532
[TBL] [Abstract][Full Text] [Related]
11. The antagonism between apigenin and protoapigenone to the PDK-1 target in Macrothelypteris torresiana.
Liu Z; Cao S; Jin C; He Y; Zhou X; Zhang H; Liu Z
Fitoterapia; 2019 Apr; 134():14-22. PubMed ID: 30731149
[TBL] [Abstract][Full Text] [Related]
12. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
13. Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π.
Chen WY; Hsieh YA; Tsai CI; Kang YF; Chang FR; Wu YC; Wu CC
Invest New Drugs; 2011 Dec; 29(6):1347-59. PubMed ID: 20686818
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids from the aerial parts of Macrothelypteris torresiana.
Fang W; Ruan J; Cai Y; Wei A; Zhou D; Zhang W
Nat Prod Res; 2011 Jan; 25(1):36-9. PubMed ID: 21240759
[TBL] [Abstract][Full Text] [Related]
15. Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway.
Chen YJ; Kay N; Yang JM; Lin CT; Chang HL; Wu YC; Fu CF; Chang Y; Lo S; Hou MF; Lee YC; Hsieh YC; Yuan SS
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):8-18. PubMed ID: 23387868
[TBL] [Abstract][Full Text] [Related]
16. New synthetic flavone derivatives induce apoptosis of hepatocarcinoma cells.
Liu H; Dong A; Gao C; Tan C; Xie Z; Zu X; Qu L; Jiang Y
Bioorg Med Chem; 2010 Sep; 18(17):6322-8. PubMed ID: 20674374
[TBL] [Abstract][Full Text] [Related]
17. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
18. Structure-affinity relationship of flavones on binding to serum albumins: effect of hydroxyl groups on ring A.
Xiao J; Cao H; Wang Y; Yamamoto K; Wei X
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S253-60. PubMed ID: 20306480
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel flavone derivatives possessing substituted benzamides and their biological evaluation against human cancer cells.
Yun BH; Lee YH; Park KT; Jung SJ; Lee YS
Bioorg Med Chem Lett; 2016 Sep; 26(17):4170-3. PubMed ID: 27503682
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
